Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 14, Issue 19
|
pp. 7986–8000
High FHL2 mRNA expression and its prognostic value in lung cancer
Back to article
Figure 2
(2 of 10)
−
100%
+
Figure 2.
ROC curve to assess the diagnostic ability of FHL2 at different stages.
(
A
) The diagnostic value of FHL2 in lung cancer patients. (
B
–
E
) Diagnostic value of FHL2 in patients with stage I, stage II, stage III, and stage IV.